Literature DB >> 9314256

Human recombinant growth hormone increases small bowel lengthening after massive small bowel resection in piglets.

P H Benhamou1, J P Canarelli, S Richard, C Cordonnier, J P Postel, E Grenier, A Leke, C Dupont.   

Abstract

BACKGROUND/
PURPOSE: Dramatic improvement in small bowel lengthening and in weight gain has been demonstrated in newborn rats treated with human growth hormone (GH) after massive small bowel resection. The aim of this study was to confirm these results in another animal model and to specify the part food intake plays in small bowel lengthening induced by GH.
METHODS: Twenty-five piglets underwent laparotomy at day 28 of life. Intestinal length was measured under general anesthesia, and animals had an 80% resection of small bowel, leaving a similar length of jejunum and ileon. There were no perioperative deaths. One animal died 3 days after surgery. Animals were assigned to five groups: (1) S (n = 4): sham, mere laparotomy; (2) GH-S (n = 4): sham and GH treatment (0.1 IU/kg/d subcutaneously); (3) R (n = 7): intestinal resection; (4) GH-R (n = 6); and (5) GH-R AdL (n = 4): intestinal resection and GH treatment. S, GH-R, and GH-R AdL had a free diet; GH-S and GH-R were pair-fed with S and R, respectively. Animals were killed 28 days later.
RESULTS: Weight gain was not different in the two nonresected groups (S, 144 +/- 6% of initial weight; GH-S, 150 +/- 3%) and was significantly higher than in the resected groups (R, 67 +/- 28%; GH-R, 74 +/- 16%; GH-R AdL, 55 +/- 16%; NS). GH did not enhance small bowel lengthening in the nonresected groups; S, 41.9 +/- 23% and GH-S, 36.9 +/- 9%, in sharp contrast with the resected groups; R, 28 +/- 9 cm versus GH-R, 96 +/- 39 cm (P = .0008) and versus GH-R AdL, 89 +/- 41 cm (P = .003). Compared with initial length, the increase was R, 16.2 +/- 5%; GH-R, 56.5 +/- 24%; GH-R AdL, 51 +/- 25%. Villus height and diameter, average number of mitosis per field, intestinal muscular layer, wall thickness, and crypt ratio were higher in resected groups than in unresected ones, with no difference observed between resected groups.
CONCLUSIONS: GH improves the postoperative intestinal adaptation process after massive small bowel resection in newborn piglets in terms of small bowel lengthening. In contrast to rats, GH did not improve weight gain. In addition, no difference was observed whether animals were on a free or a controlled diet.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9314256     DOI: 10.1016/s0022-3468(97)90315-8

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  12 in total

Review 1.  Somatropin (Zorbtive): in short bowel syndrome.

Authors:  Gillian M Keating; Keri Wellington
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 2.  Intestinal mucosal adaptation.

Authors:  Laurie Drozdowski; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

Review 3.  Animal models of gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: translational relevance and challenges.

Authors:  Per T Sangild; Denise M Ney; David L Sigalet; Andreas Vegge; Douglas Burrin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-23       Impact factor: 4.052

Review 4.  The alpha-smooth muscle actin promoter: a useful tool to analyse autocrine and paracrine roles of mesenchymal cells in normal and diseased bowel.

Authors:  P K Lund
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

5.  Adult zebrafish intestine resection: a novel model of short bowel syndrome, adaptation, and intestinal stem cell regeneration.

Authors:  K A Schall; K A Holoyda; C N Grant; D E Levin; E R Torres; A Maxwell; H A Pollack; R A Moats; M R Frey; A Darehzereshki; D Al Alam; C Lien; T C Grikscheit
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-06-18       Impact factor: 4.052

Review 6.  Porcine models of digestive disease: the future of large animal translational research.

Authors:  Liara M Gonzalez; Adam J Moeser; Anthony T Blikslager
Journal:  Transl Res       Date:  2015-01-13       Impact factor: 7.012

Review 7.  Morphological, kinetic, membrane biochemical and genetic aspects of intestinal enteroplasticity.

Authors:  Laurie A Drozdowski; M Tom Clandinin; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

8.  Effects of recombinant human growth hormone on enterocutaneous fistula patients.

Authors:  Guo-Sheng Gu; Jian-An Ren; Ning Li; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

Review 9.  Novel therapies for the management of short bowel syndrome in children.

Authors:  Marshall Z Schwartz
Journal:  Pediatr Surg Int       Date:  2013-10       Impact factor: 1.827

10.  Short bowel syndrome results in increased gene expression associated with proliferation, inflammation, bile acid synthesis and immune system activation: RNA sequencing a zebrafish SBS model.

Authors:  Kathy A Schall; Matthew E Thornton; Mubina Isani; Kathleen A Holoyda; Xiaogang Hou; Ching-Ling Lien; Brendan H Grubbs; Tracy C Grikscheit
Journal:  BMC Genomics       Date:  2017-01-25       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.